KT185 是口服有效的、能透过血脑屏障的ABHD6 的选择性抑制剂,其在 Neuro2A 细胞中测得的 IC50 值为0.21 nM。
暂无科研文献
KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells.
Room temperature in continental US; may vary elsewhere.
纯度: 98%